Dr. Sara Gandini
Sara has a degree in Statistics (110 cum laude, University of Bologna, Italy), an MSc in Biometry (University of Reading, UK) and a PhD in Cancer Studies (University of Birmingham, UK). She is a senior investigator (vice-director) at the division of Epidemiology and Biostatistics, at the European Institute of Oncology in Milan (Italy) providing constant consultation in a wide range of areas including statistical design of experiments and clinical trials, protocol development, analysis of data and interpretation of results.
Sara has conducted extensive research in cancer epidemiology, including systematic reviews and meta-analyses. In the last years her main interest has been in melanoma epidemiology and on the role of Vitamin D in cancer epidemiology. She is the lead organizer of a multicentre Italian trial on Vitamin D supplementation for melanoma patients and a trial on Vitamin D and microbiota for colorectal cancer.
She is the author of more than 100 publications in peer-reviewed scientific journals (total citations: 5149; average cit. per year: 282; h-index=35).
- 2014 AIRC: Principal investigator of “Effect of Vitamin D on microbiome in colorectal cancer.”
- 2013 Fondazione Umberto Veronesi: Principal investigator of “Relationship between microbiota, Vitamin D and colorectal cancer: towards new possible cancer prevention strategies.”
- 2012 European Espace Agency (ESA): Research Using Concordia Antarctic Station as Human Exploration Analogue: Member of the team for the project: “Impact of Vitamin D supplementation on health markers at Concordia (VITAD)”
- 2010 Fondazione Umberto Veronesi: Principal investigator of a project on “Biomarkers studies on stage II melanoma patients treated with Vitamin D”.